Marc Rubin Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Marc Rubin.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Marc Rubin. Marc Rubin is a Director in MEDAREX INC ($MEDX) and an Executive Chairman in TITAN PHARMACEUTICALS INC ($TTNP) and a Director in CURIS INC ($CRIS) and a Director in GALECTIN THERAPEUTICS INC ($GALT).

Address: 130 WALNUT STREET ENGLEWOOD 07631 NJ

Companies in which Marc Rubin is an Insider

CURIS INC

Trading Symbol: CRIS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Rubin: Director
Holdings: 28,819 shares
Current Value: $78,676
Latest Transaction: Mar 04 2020
$CRIS Market Capitalization: $368.24M
$CRIS Previous Close: $2.73

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GALECTIN THERAPEUTICS INC

Trading Symbol: GALT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Rubin: Director
Holdings: 13,581 shares
Current Value: $17,248
Latest Transaction: Mar 29 2021
$GALT Market Capitalization: $34.39M
$GALT Previous Close: $1.27

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

MEDAREX INC

Trading Symbol: MEDX
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Marc Rubin: Director
Holdings: 0 shares
Latest Transaction: Sep 03 2009

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

TITAN PHARMACEUTICALS INC

Trading Symbol: TTNP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Rubin: Executive Chairman
Holdings: 556,317 shares
Current Value: $2,197,452
Latest Transaction: Feb 11 2021
$TTNP Market Capitalization: $81.61M
$TTNP Previous Close: $3.95

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Marc Rubin

Sentiment: All, CRIS, GALT, MEDX, TTNP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 29 2021GALTGALECTIN THERAPEUT ...Rubin MarcDirectorOption ExerciseA2.1170,000147,70070,000
Mar 29 2021GALTGALECTIN THERAPEUT ...Rubin MarcDirectorOption ExerciseA2.1140,00084,40040,000
Feb 11 2021TTNPTITAN PHARMACEUTIC ...Rubin MarcExecutive ChairmanOption ExerciseA4.02150,000603,000150,000
Mar 04 2020CRISCURIS INCRubin MarcDirectorOption ExerciseA1.26180,000226,800180,000
Jan 13 2020GALTGALECTIN THERAPEUT ...Rubin MarcDirectorOption ExerciseA2.8630,00085,80030,000
Apr 03 2019TTNPTITAN PHARMACEUTIC ...Rubin MarcExecutive ChairmanOption ExerciseA1.75200,000350,000200,000
Feb 25 2019GALTGALECTIN THERAPEUT ...Rubin MarcDirectorOption ExerciseM2.398592,05333,065

View all Marc Rubin insider transactions.

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

What Should I Do When Insiders Are Selling Stock?

It's often said that insider selling can be a hint that they know that their stock is about to underperform the market. Even though this is true in some cases, it's also true that insider selling is frequently simply behind financial reasons of the insiders and have no connection with the company's prospects. More ...

Are IPOs Interesting for Small Investors?

Initial Public Offering is the first sale of stock by a privately owned company to the public. Companies negotiate a sale of their stock to an investment banker or several bankers that act as an underwriter for the offering. More ...

Contact us | Follow us on Twitter